Skip to main content

Peer Review reports

From: Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)

Original Submission
20 Jun 2023 Submitted Original manuscript
28 Jun 2023 Reviewed Reviewer Report
16 Oct 2023 Reviewed Reviewer Report
9 Nov 2023 Author responded Author comments - Chikashi Ishioka
Resubmission - Version 2
9 Nov 2023 Submitted Manuscript version 2
15 Jan 2024 Reviewed Reviewer Report
20 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Author responded Author comments - Chikashi Ishioka
Resubmission - Version 3
29 Jan 2024 Submitted Manuscript version 3
30 Jan 2024 Author responded Author comments - Chikashi Ishioka
Resubmission - Version 4
30 Jan 2024 Submitted Manuscript version 4
2 Feb 2024 Reviewed Reviewer Report
5 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
6 Feb 2024 Editorially accepted
24 Feb 2024 Article published 10.1186/s12885-024-11973-9

You can find further information about peer review here.

Back to article page